About the study
- Participation is voluntary.
- You will not be charged for any specific actions taken as part of this study.
- The data collected as part of your participation are confidential. Your anonymity will be assured when the results are published.
- Before you agree to participate in this study, we ask you to familiarize yourself with what this study will entail so that you can make an informed decision.
Silicon chip technology allowing for ultra-fast PCR
Built-in controls ensure the highest quality result
Proven sensitivity equal to reference lab-based PCR
PCR designs cover variants of concern
Both testcard (disposable) and reader are highly scalable
Optimized to reduce hands-on time and enabling high throughput
“miDiagnostics has the potential to disrupt and transform the industry by making diagnostic information available to clinician and patient alike.”
“Its easy-to-use and cost-efficient test will revolutionize point-of-care testing by directly engaging with patients and enabling speedy intervention.”
“Proud to be leading a top team and together with our numerous partners to make a significant contribution to healthcare in general.”